These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3308083

  • 1. Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
    Triozzi PL, Kenney P, Young D, Rinehart JJ.
    Cancer Treat Rep; 1987 Oct; 71(10):983-4. PubMed ID: 3308083
    [No Abstract] [Full Text] [Related]

  • 2. Phase II trial of recombinant beta interferon in advanced colorectal cancer.
    Lillis PK, Brown TD, Beougher K, Koeller J, Marcus SG, Von Hoff DD.
    Cancer Treat Rep; 1987 Oct; 71(10):965-7. PubMed ID: 3308080
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum.
    Figlin RA, Callaghan M, Sarna G.
    Cancer Treat Rep; 1983 May; 67(5):493-4. PubMed ID: 6850664
    [Abstract] [Full Text] [Related]

  • 4. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J, Malspeis L, Young D, Neidhart J.
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [Abstract] [Full Text] [Related]

  • 5. Beta=interferon in the treatment of 14 patients with advanced colorectal carcinoma.
    Pitini V, Palmara D, Ferraro G, Zanghi M, La Torre F, Tomasella R, Chille G.
    J Exp Pathol; 1987 Oct; 3(4):603-5. PubMed ID: 3454807
    [No Abstract] [Full Text] [Related]

  • 6. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
    Jacqmin D, Bergerat JP, Dufour P, Bollack C, Prévot G, Jurascheck F, Bailly G, Degaris S, Oberling F.
    J Urol (Paris); 1987 Oct; 93(8):463-6. PubMed ID: 3440838
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
    Chaplinski T, Laszlo J, Moore J, Silverman P.
    Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of high-dose recombinant leukocyte alpha-2 interferon for metastatic colorectal cancer without previous systemic treatment.
    Eggermont AM, Weimar W, Marquet RL, Laméris JD, Jeekel J.
    Cancer Treat Rep; 1985 Feb; 69(2):185-7. PubMed ID: 3882227
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group study.
    Von Hoff DD, Metch B, Lucas JG, Balcerzak SP, Grunberg SM, Rivkin SE.
    J Interferon Res; 1990 Oct; 10(5):531-4. PubMed ID: 2273299
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R, Scheithauer W, Ludwig H, Flener R.
    Acta Med Austriaca; 1985 Oct; 12(5):129-34. PubMed ID: 3938590
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
    Sarna G, Pertcheck M, Figlin R, Ardalan B.
    Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
    [Abstract] [Full Text] [Related]

  • 17. Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (trial 1) and in combination with 5-fluorouracil (trial 2) in advanced colorectal cancer.
    Clark PI, Slevin ML, Reznek RH, Niederle N, Kurschel E, Lundell G, Cedermark B, Fallenius A, Blomgren H, Ohman U.
    Int J Colorectal Dis; 1987 Feb; 2(1):26-9. PubMed ID: 3598328
    [Abstract] [Full Text] [Related]

  • 18. [Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon].
    Aulitzky W, Gastl G, Troppmair J, Tilg H, Abbrederis K, Nerl C, Flener R, Rokos H, Huber C.
    Acta Med Austriaca; 1985 Feb; 12(5):115-21. PubMed ID: 3832745
    [Abstract] [Full Text] [Related]

  • 19. Does maintenance therapy with alpha interferon stabilize cancer growth? A pilot study.
    Laszlo J, Goldstein D, Vugrin D, Hood L, Tso CY.
    J Biol Response Mod; 1986 Aug; 5(4):294-9. PubMed ID: 3734845
    [Abstract] [Full Text] [Related]

  • 20. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP.
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.